I think it will start at $10-$15. But out of desperation to get rid of the competition(threat), they will offer more. But not likely more than $20 as that is getting too expensive for them A $25 offer and their stockholders will have a fit.

Remdisvir has never been a success story for them. I truly believe they need an HIV product, as that's what they are known for.